| Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia XS Puente, M Pinyol, V Quesada, L Conde, GR Ordóñez, N Villamor, ... Nature 475 (7354), 101-105, 2011 | 1964 | 2011 |
| Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia V Quesada, L Conde, N Villamor, GR Ordóñez, P Jares, L Bassaganyas, ... Nature genetics 44 (1), 47-52, 2012 | 1295 | 2012 |
| The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated … J Dierlamm, M Baens, I Wlodarska, M Stefanova-Ouzounova, ... Blood, The Journal of the American Society of Hematology 93 (11), 3601-3609, 1999 | 886 | 1999 |
| Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in … T Haferlach, A Kohlmann, L Wieczorek, G Basso, GT Kronnie, MC Béné, ... Journal of clinical oncology 28 (15), 2529-2537, 2010 | 757 | 2010 |
| Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics R Garcıa-Sanz, A Orfao, M Gonzalez, MD Tabernero, J Bladé, MJ Moro, ... Blood, The Journal of the American Society of Hematology 93 (3), 1032-1037, 1999 | 462 | 1999 |
| Characterization of acute promyelocytic leukemia cases lacking the classic t (15; 17): results of the European Working Party D Grimwade, A Biondi, MJ Mozziconacci, A Hagemeijer, R Berger, M Neat, ... Blood, The Journal of the American Society of Hematology 96 (4), 1297-1308, 2000 | 460 | 2000 |
| High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a … J Bladé, L Rosinol, A Sureda, JM Ribera, J Díaz-Mediavilla, ... Blood 106 (12), 3755-3759, 2005 | 418 | 2005 |
| Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients JF San Miguel, A Martınez, A Macedo, MB Vidriales, C Lopez-Berges, ... Blood, The Journal of the American Society of Hematology 90 (6), 2465-2470, 1997 | 345 | 1997 |
| Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling NC Gutiérrez, ME Sarasquete, I Misiewicz-Krzeminska, M Delgado, ... Leukemia 24 (3), 629-637, 2010 | 266 | 2010 |
| NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome N Villamor, L Conde, A Martínez-Trillos, M Cazorla, A Navarro, S Bea, ... Leukemia 27 (5), 1100-1106, 2013 | 253 | 2013 |
| An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study … A Kohlmann, TJ Kipps, LZ Rassenti, JR Downing, SA Shurtleff, KI Mills, ... British journal of haematology 142 (5), 802-807, 2008 | 239 | 2008 |
| Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic … NC Gutierrez, EM Ocio, J de Las Rivas, P Maiso, M Delgado, E Ferminan, ... Leukemia 21 (3), 541-549, 2007 | 231 | 2007 |
| Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t (4; 14) is the most relevant adverse … NC Gutierrez, MV Castellanos, ML Martin, MV Mateos, JM Hernandez, ... Leukemia 21 (1), 143-150, 2007 | 228 | 2007 |
| Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes JA Perez-Simon, R Garcıa-Sanz, MD Tabernero, J Almeida, M Gonzalez, ... Blood, The Journal of the American Society of Hematology 91 (9), 3366-3371, 1998 | 220 | 1998 |
| The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma R García-Sanz, JR González-Porras, JM Hernandez, M Polo-Zarzuela, ... Leukemia 18 (4), 856-863, 2004 | 218 | 2004 |
| Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome KI Mills, A Kohlmann, PM Williams, L Wieczorek, W Liu, R Li, W Wei, ... Blood, The Journal of the American Society of Hematology 114 (5), 1063-1072, 2009 | 213 | 2009 |
| Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome JF San Miguel, J Almeida, G Mateo, J Bladé, C López-Berges, ... Blood, The Journal of the American Society of Hematology 99 (5), 1853-1856, 2002 | 211 | 2002 |
| A new staging system for multiple myeloma based on the number of S-phase plasma cells JF San Miguel, R Garcia-Sanz, M Gonzalez, MJ Moro, JM Hernandez, ... | 206 | 1995 |
| Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t (8; 13)(p11; q12) myeloproliferative syndrome A Reiter, J Sohal, S Kulkarni, A Chase, DHC Macdonald, RCT Aguiar, ... Blood, The Journal of the American Society of Hematology 92 (5), 1735-1742, 1998 | 194 | 1998 |
| Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome O Lopez-Villar, JL Garcia, FM Sanchez-Guijo, C Robledo, EM Villarón, ... Leukemia 23 (4), 664-672, 2009 | 193 | 2009 |
